![Alvin Lin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alvin Lin currently works at Vera Therapeutics, Inc., as Vice President-Commercial Strategy.
Mr. Lin also formerly worked at Pharmacyclics LLC, as Head-US Leukemia Marketing and Portola Pharmaceuticals LLC, as Head-Lifecycle Management & Strategic Marketing.
Mr. Lin received his undergraduate degree from Massachusetts Institute of Technology and graduate degree from Tufts University School of Medicine.
| Companies | Position | Start |
|---|---|---|
| VERA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
| PHARMACYCLICS, INC. | Sales & Marketing | - |
| PORTOLA PHARMACEUTICALS, INC. | Sales & Marketing | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 6 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vera Therapeutics, Inc.
 Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
